Symmetry Partners’s Exelixis EXEL Stock Holding History

Symmetry Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,504	Closed	-$361K	–	310
2019 Q4	$361K	Buy	20,504 +10,070	+97%	+$171K	0.07%	219
2019 Q3	$185K	Buy	+10,434	New	+$211K	0.04%	328

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Symmetry Partners's EXEL Position: Q1 2020 in Review

Symmetry Partners sold out of Exelixis (EXEL) in Q1 2020, closing a stake of 20,504 shares — an estimated $361K sold.

Symmetry Partners first reported a position in EXEL in Q3 2019 and held it in 2 quarters. The position peaked at $361K in Q4 2019. 336 funds tracked by Wall St. Rank hold EXEL as of Q1 2020.

Symmetry Partners reported no remaining Exelixis position as of Q1 2020 after selling out during the quarter.
Symmetry Partners sold 20,504 Exelixis shares in Q1 2020, an estimated $361K.
Symmetry Partners first reported a position in Exelixis in Q3 2019 and held it in 2 quarters.
Symmetry Partners's Exelixis position peaked at $361K in Q4 2019.
336 funds tracked by Wall St. Rank held Exelixis as of Q1 2020.

Based on Symmetry Partners's 13F filing for Q1 2020, filed 15 May 2020.